EXAGEN INC. (XGN) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $517.00K; Long-term Debt, Excluding Current MaturitiesUSD $22.32M; Long-term DebtUSD $22.84M; Long-Term Debt, Maturity, Year OneUSD $3.45M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $580.00K; Long-term Debt, Excluding Current MaturitiesUSD $22.29M; Long-term DebtUSD $22.87M; Long-Term Debt, Maturity, Year OneUSD $3.45M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $643.00K; Long-term Debt, Excluding Current MaturitiesUSD $22.26M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $22.91M; Long-Term Debt, Maturity, Year OneUSD $3.70M.
EXAGEN INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $517.00K | $22.32M | $22.84M | $3.45M | $3.12M | $2.98M | $25.93M | (m) | $1.84M | $3.03M |
| 2026-03-31 | $580.00K | $22.29M | $22.87M | $3.45M | $3.12M | $2.98M | $25.93M | (m) | $2.77M | $3.17M |
| 2025-12-31 | $643.00K | $22.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $22.91M | $3.70M | $3.45M | $3.12M | $2.98M | $25.93M | (m) | $3.30M |
| 2025-09-30 | $680.00K | $22.26M | $22.94M | $3.70M | $3.45M | $3.12M | $2.98M | $25.93M | $944.00K | $3.43M |
| 2025-06-30 | $667.00K | $22.31M | $22.98M | $3.70M | $3.45M | $3.12M | $2.98M | $25.93M | $1.89M | $3.56M |
| 2025-03-31 | $2.54M | $18.41M | $20.94M | $21.66M | $472.00K | $88.00K | (m) | (m) | $1.80M | $60.00K |
| 2024-12-31 | $423.00K | $19.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $20.25M | $2.08M | $21.40M | $215.00K | $67.00K | (m) | (m) | $70.00K |
| 2024-09-30 | $430.00K | $19.82M | $20.25M | $2.10M | $21.40M | $215.00K | $67.00K | (m) | $517.00K | $80.00K |
| 2024-06-30 | $423.00K | $19.83M | $20.25M | $2.19M | $21.48M | $215.00K | $67.00K | (m) | $1.09M | $93.00K |
| 2024-03-31 | $268.00K | $19.27M | $19.54M | $1.97M | $21.24M | (m) | (m) | (m) | $1.47M | $103.00K |
| 2023-12-31 | $264.00K | $19.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $19.50M | $1.95M | $1.97M | $21.24M | (m) | (m) | (m) | $113.00K |
| 2023-09-30 | $261.00K | $19.19M | $19.45M | $1.95M | $1.97M | $21.24M | (m) | (m) | $487.00K | $124.00K |
| 2023-06-30 | $257.00K | $19.15M | $19.41M | $1.91M | $1.93M | $21.21M | (m) | (m) | $950.00K | $134.00K |
| 2023-03-31 | $254.00K | $29.09M | $29.35M | $3.28M | $16.45M | $15.04M | (m) | (m) | $1.50M | $145.00K |
| 2022-12-31 | $190.00K | $28.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $28.97M | $1.91M | $3.21M | $16.38M | $14.97M | (m) | (m) | $158.00K |
| 2022-09-30 | (m) | $28.01M | $28.01M | $1.69M | $2.98M | $16.15M | $14.79M | (m) | $420.00K | $170.00K |
| 2022-06-30 | (m) | $27.83M | $27.83M | $1.69M | $2.98M | $16.15M | $14.79M | (m) | $837.00K | $182.00K |
| 2022-03-31 | (m) | $27.65M | $27.65M | $1.69M | $2.98M | $16.15M | $14.79M | (m) | $1.25M | $195.00K |
| 2021-12-31 | $0.00 | $27.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $27.48M | $1.65M | $1.69M | $2.98M | $16.15M | $14.79M | (m) | $208.00K |
| 2021-09-30 | (m) | $27.29M | $27.29M | $3.00M | $15.62M | $14.28M | (m) | (m) | $446.00K | $224.00K |
| 2021-06-30 | (m) | $27.07M | $27.07M | $3.00M | $15.62M | $14.28M | (m) | (m) | $889.00K | $249.00K |
| 2021-03-31 | (m) | $26.86M | $26.86M | $3.00M | $15.62M | $14.28M | $0.00 | (m) | $1.33M | $273.00K |
| 2020-12-31 | (m) | $26.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $26.66M | $1.75M | $3.00M | $15.62M | $14.28M | (m) | (m) | $296.00K |
| 2020-09-30 | (m) | $26.45M | $26.45M | $1.75M | $3.00M | $15.62M | $14.28M | (m) | $437.00K | $320.00K |
| 2020-06-30 | (m) | $26.25M | $26.25M | $1.75M | $3.00M | $15.62M | $14.28M | (m) | $872.00K | $344.00K |
| 2020-03-31 | (m) | $26.05M | $26.05M | (m) | $1.75M | $3.00M | $15.62M | $14.28M | $1.30M | $367.00K |
| 2019-12-31 | (m) | $25.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $25.85M | $1.73M | $1.75M | $3.00M | $15.62M | $14.28M | (m) | $390.00K |
| 2019-09-30 | (m) | $25.68M | $25.68M | (m) | $6.12M | $14.94M | $11.25M | (m) | $725.00K | $484.00K |
| 2018-12-31 | (m) | $24.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |